PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16520895-11	2006	However, Bcl-2 is further enhanced following prolactin stimulation for 4 h and this enhancement is blocked by DFMO.	Eflornithine	110-114	BCL2 apoptosis regulator	Homo sapiens	9-14	
16520895-12	2006	Bcl-2 has no effect on ODC activity and protein levels, but ODC upregulates Bcl-2, which is inhibited by DFMO.	Eflornithine	105-109	BCL2 apoptosis regulator	Homo sapiens	76-81	
11776633-6	2000	In addition, transfection with antisense bcl-2 did not induce marked apoptosis whereas treatment of the transfectant with low concentration (0.2 mmol/L) of DFMO resulted in enhanced expression inhibition of bcl-2 protein, inhibition of cell growth and induction of apoptosis.	Eflornithine	156-160	BCL2 apoptosis regulator	Homo sapiens	207-212	
22344475-12	2012	The ODC specific inhibitor, DFMO, altered the apoptotic effects of ROSC by increasing the generation of reactive oxygen species, decreasing the PA intracellular pool and modulating pro-apoptotic and anti-apoptotic Bcl-2 family members.	Eflornithine	28-32	BCL2 apoptosis regulator	Homo sapiens	214-219	
34638596-7	2021	Additionally, significant changes in Bcl-2, Bcl-xL, Bax protein levels, activation of caspase-3, and cleavage of poly (ADP-ribose) polymerase were observed, indicating the apoptotic effects of DFMO.	Eflornithine	193-197	BCL2 apoptosis regulator	Homo sapiens	37-42